Saturday, July 11, 2026

Patent directory · USPTO A61K / A61P

Patents matching “therapy”

782 pharma patents match "therapy" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 782
Index total 30,257
Page 20 / 33

Quick answer

This filtered view shows 782 pharmaceutical patents matching "therapy" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

782 results for “therapy” · 30,257 patents in full index Clear search

  1. US 9920100

    Mimotopes of tropomyosin for use in immunotherapy for shellfish and/or arthropod allergy

    The Regents of the University of California · Granted Mar 20, 2018 · Expires Mar 15, 2038

    granted
  2. US 9913822

    Combination therapy with an anti-hyaluronan agent and therapeutic agent

    HALOZYME, INC. · Granted Mar 13, 2018 · Expires Mar 8, 2038

    granted
  3. US 9907820

    Polyclonal gamma delta T cells for immunotherapy

    The Board of Regents of the University of Texas System · Granted Mar 6, 2018 · Expires Mar 1, 2038

    granted
  4. US 9889182

    Assisted enzyme replacement therapy

    The Regents of the University of California · Granted Feb 13, 2018 · Expires Feb 8, 2038

    granted
  5. US 9889125

    Methods for treating heartburn, gastric bleeding or hemorrhage in patients receiving clopidogrel therapy

    Takeda Pharmaceuticals U.S.A., Inc. · Granted Feb 13, 2018 · Expires Feb 8, 2038

    granted
  6. US 9884076

    Optimized methods for generation of cardiac stem cells from cardiac tissue and their use in cardiac therapy

    Capricor, Inc. · Granted Feb 6, 2018 · Expires Feb 1, 2038

    granted
  7. US 9877952

    Methods for dosing an orally active 1,2,4-oxadiazole for nonsense mutation suppression therapy

    PTC THERAPEUTICS, INC. · Granted Jan 30, 2018 · Expires Jan 25, 2038

    granted
  8. US 2018000900

    COMBINATION THERAPY INVOLVING ANTIBODIES AGAINST CLAUDIN 18.2 FOR TREATMENT OF CANCER

    GANYMED PHARMACEUTICALS AG [DE] · Granted Jan 4, 2018 · Expires Dec 30, 2037

    granted
  9. US 9855330

    Granulysin in immunotherapy

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jan 2, 2018 · Expires Dec 28, 2037

    granted
  10. US 9855298

    Methods of conditioning patients for T cell therapy

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jan 2, 2018 · Expires Dec 28, 2037

    granted
  11. US 9849167

    Compositions and methods for combination therapy with dengue virus and dendritic cells

    PrimeVax Immuno-Oncology · Granted Dec 26, 2017 · Expires Dec 21, 2037

    granted
  12. US 9814789

    Radiopharmaceutical products for diagnosis and therapy of adrenal carcinoma

    Julius-Maximilians-Universitat Wurzburg · Granted Nov 14, 2017 · Expires Nov 9, 2037

    granted
  13. US 9808543

    Iron garnet nanoparticles for cancer radiotherapy and chemotherapy

    The Board of Regents of the University of Texas System · Granted Nov 7, 2017 · Expires Nov 2, 2037

    granted
  14. US 9808486

    Administration of kynurenine depleting enzymes for tumor therapy

    The Board of Regents of the University of Texas System · Granted Nov 7, 2017 · Expires Nov 2, 2037

    granted
  15. US 9789162

    Systemic and local ex vivo gene therapy of the skeleton

    The United States of America as represented by the Department of Veteran Affairs · Granted Oct 17, 2017 · Expires Oct 12, 2037

    granted
  16. US 9789096

    Methods and compositions for selective and targeted cancer therapy

    The Board of Regents of the University of Texas System · Granted Oct 17, 2017 · Expires Oct 12, 2037

    granted
  17. US 9789224

    Compositions and methods for cardiac therapy

    The Regents of the University of California · Granted Oct 17, 2017 · Expires Oct 12, 2037

    granted
  18. US 9789205

    Compositions and methods for gene therapy

    BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Oct 17, 2017 · Expires Oct 12, 2037

    granted
  19. US 9765147

    Anti-CSFR1 antibody and anti PD-1 antibody combination therapy for cancer

    Five Prime Therapeutics, Inc. · Granted Sep 19, 2017 · Expires Sep 14, 2037

    granted
  20. US 9757420

    Gene editing for HIV gene therapy

    Sangamo Therapeutics, Inc. · Granted Sep 12, 2017 · Expires Sep 7, 2037

    granted
  21. US 9737513

    Methods for dosing an orally active 1,2,4-oxadiazole for nonsense mutation suppression therapy

    PTC THERAPEUTICS, INC. · Granted Aug 22, 2017 · Expires Aug 17, 2037

    granted
  22. US 9730989

    Compositions and methods for combination therapy with dengue virus and dendritic cells

    PrimeVax Immuno-Oncology · Granted Aug 15, 2017 · Expires Aug 10, 2037

    granted
  23. US 9731023

    Somatostatin receptor-based cancer therapy

    The Board of Regents of the University of Texas System · Granted Aug 15, 2017 · Expires Aug 10, 2037

    granted
  24. US 9694074

    Functionalized porous silicon nanoparticles and use thereof in photodynamic therapy

    The Regents of the University of California · Granted Jul 4, 2017 · Expires Jun 29, 2037

    granted